Iron Deficiency Anemia of Pregnancy
Hematology
1
Pipeline Programs
2
Companies
2
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Arrowhead PharmaceuticalsPASADENA, CA
1 program1
Venofer 200 MG Per 10 ML InjectionPhase 31 trial
Active Trials
United TherapeuticsMD - Silver Spring
1 programAdiposity and Iron Requirements in PregnancyN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2023
2024
2025
2026
Arrowhead PharmaceuticalsVenofer 200 MG Per 10 ML Injection
United TherapeuticsAdiposity and Iron Requirements in Pregnancy
Clinical Trials (2)
Total enrollment: 1,212 patients across 2 trials
Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia
Start: Nov 2023Est. completion: Dec 2025900 patients
Phase 3Recruiting
Adiposity and Iron Requirements in Pregnancy
Start: May 2024Est. completion: Jan 2026312 patients
N/ARecruiting
Related Jobs in Hematology
Senior Manager – Strategy & Business Transformation
Johnson & Johnson
Mumbai, India
2d ago
MSL Hematología L - Sur
Johnson & Johnson
Sevilla, Spain
2d ago
Délégué Médical LLC/Myélome (H/F) - secteurToulouse
Johnson & Johnson
Issy-les-Moulineaux, France
2d ago
Sr. Director Marketing
Genetix Biotherapeutics
Somerville, Massachusetts, United States
5d ago
From $270K/yr
Commercial Strategy Lead – Innovative Gene Therapies (Haematology - BeNeLux)
Vertex Pharmaceuticals
5065 - Vertex Netherlands
5d ago
Key Account Specialist Hematology
Johnson & Johnson
Beirut, Lebanon
5d ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
2 actively recruiting trials targeting 1,212 patients
2 companies competing in this space